Long-term survival after endoscopic resection for early gastric cancer in the remnant stomach: comparison with radical surgery

Endoscopic resection (ER) has recently become standard treatment, even for early gastric cancer (EGC) in the remnant stomach. We aimed to compare long-term survival after ER versus radical surgery for EGC in the remnant stomach. We retrospectively compared overall and cause-specific survival of pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of gastroenterology 2015-01, Vol.28 (1), p.66-71
Hauptverfasser: Yamashina, Takeshi, Uedo, Noriya, Dainaka, Katsuyuki, Aoi, Kenji, Matsuura, Noriko, Ito, Takashi, Fujii, Mototsugu, Kanesaka, Takashi, Yamamoto, Sachiko, Akasaka, Tomofumi, Hanaoka, Noboru, Takeuchi, Yoji, Higashino, Koji, Ishihara, Ryu, Kishi, Kentaro, Fujiwara, Yoshiyuki, Iishi, Hiroyasu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Endoscopic resection (ER) has recently become standard treatment, even for early gastric cancer (EGC) in the remnant stomach. We aimed to compare long-term survival after ER versus radical surgery for EGC in the remnant stomach. We retrospectively compared overall and cause-specific survival of patients who had undergone ER or radical surgery for EGC in the remnant stomach from 1998 to 2012. During the study period, 32 patients with intramucosal (M), two with shallow submucosal (SM1) and eight with deep submucosal (SM2) cancers had undergone ER (ER group) whereas six with M and seven with SM2 cancers had undergone surgery (surgery group). All patients were followed up for a median of 60 months; during follow up, 15 patients died, including three in the ER group with SM2 cancer who died of gastric cancer. The overall 5-year survival rates of M-SM1 and SM2 cancer patients in the ER and surgery groups were 89%, 48%, 80%, and 67%, respectively (P=0.079). The disease-specific 5-year survival rates of M-SM1 and SM2 cancer patients in the ER and surgery groups were 100%, 48%, 100%, and 100%, respectively (P=0.000). Operation time and hospital stay were significantly shorter in the ER than the surgery group (P
ISSN:1108-7471
1792-7463